Clinical Trial | Sleep


We are investigating cannabidiol (CBD) as a potential new treatment for sleep disturbances.  The phase III clinical trial is currently under way in Australia with results expected to be available later in the year (2022).

Presently, CBD cannot be purchased over the counter in Australia; it is only available through a Special Access Scheme and prescribed by an Authorised Prescriber.  The trial aims to produce enough evidence to have our capsules listed on the Australian Register of Therapeutic Goods and be available over the counter in pharmacies.

This exciting news has made the headlines in Australia with Channel 9 covering it across states on their National Nine News program, check it out on the link below.

Full details of the trial can be found here.




  • Share on: